EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
CG Oncology, Inc. (CGON) had EBIT Margin of -2097.33% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$2.32M |
|
$-41.31M |
|
$3.07M |
|
$-0.75M |
|
$51.02M |
|
$-48.70M |
|
$7.39M |
|
$-41.31M |
|
$-41.31M |
|
$-41.31M |
|
$-41.31M |
|
$-41.31M |
|
$-41.31M |
|
$-48.70M |
|
$-46.90M |
|
77.30M |
|
77.30M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$759.48M |
|
$15.60M |
|
$32.12M |
|
$791.59M |
|
$30.84M |
|
$3.00M |
|
$8.15M |
|
$38.99M |
|
$752.60M |
|
$741.73M |
|
$752.60M |
|
80.69M |
|
| Cash Flow Statement Financials | |
$-132.35M |
|
$-245.82M |
|
$153.59M |
|
$257.07M |
|
$32.49M |
|
$-224.58M |
|
$26.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.63 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-32.21% |
|
-2097.33% |
|
|
EBIT Margin |
-2097.33% |
-- |
|
-1779.03% |
|
-1779.03% |
|
$-132.48M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
1.96 |
|
3.38 |
|
26.67 |
|
-5.49% |
|
-5.57% |
|
-5.22% |
|
-5.47% |
|
$9.33 |
|
$-1.71 |
|
$-1.71 |
|